Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
Liran I. Shlush(Maccabi Healthcare Services), Karl Skorecki(Bar-Ilan University), Alan R. Templeton(Washington University in St. Louis), Guennady Yudkovsky(Technion – Israel Institute of Technology), Dan Geiger(Technion – Israel Institute of Technology), Sivan Bercovici(Fresenius Medical Care (United States)), Walter G. Wasser(Cabrini Medical Center)
Cited by 34
Related Papers
Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease
|Nature Microbiology|2019|1k
Insulin Production by Human Embryonic Stem Cells
|Diabetes|2001|907
Deep resequencing reveals excess rare recent variants consistent with explosive population growth
|Nature Communications|2010|243